Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II StudyJean Louis Lefèbvre, É. Bardet, Frédéric Rolland et al.|Journal of Clinical Oncology|2013Cited by 418
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trialJ. Guigay, Franck Darloy, Olivier Capitain et al.|The Lancet Oncology|2021Cited by 231
French consensus regarding precautions during tracheostomy and post-tracheostomy care in the context of COVID-19 pandemicPhilippe Schultz, I. Atallah, S. Bartier et al.|European Annals of Otorhinolaryngology Head and Neck Diseases|2020Cited by 76
Dix ans de progrès en chirurgie des tumeurs de la tête et du cou, quel impact sur la radiothérapie postopératoire ?Juliette Thariat, E. Babin, Vianney Bastit et al.|Bulletin du Cancer|2020Cited by 6